FFP
EW icon

FourThought Financial Partners’s Edwards Lifesciences EW Stock Holding History

FourThought Financial Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,398
Closed -$264K – 545
2025
Q3 		$264K Buy
+3,398
New +$265K 0.02% 392
2024
Q2 		– Sell
-2,827
Closed -$270K – 235
2024
Q1 		$270K Sell
2,827
-298
-10% -$25K 0.03% 268
2023
Q4 		$238K Sell
3,125
-152
-5% -$10.6K 0.03% 280
2023
Q3 		$227K Sell
3,277
-269
-8% -$21.6K 0.03% 287
2023
Q2 		$334K Sell
3,546
-172
-5% -$14.9K 0.04% 233
2023
Q1 		$308K Sell
3,718
-63
-2% -$4.95K 0.04% 246
2022
Q4 		$282K Buy
+3,781
New +$291K 0.04% 260

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

FourThought Financial Partners's EW Position: Q4 2025 in Review

FourThought Financial Partners sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 3,398 shares — an estimated $264K sold.

FourThought Financial Partners first reported a position in EW in Q4 2022 and held it in 7 quarters. The position peaked at $334K in Q2 2023. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • FourThought Financial Partners reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
  • FourThought Financial Partners sold 3,398 Edwards Lifesciences shares in Q4 2025, an estimated $264K.
  • FourThought Financial Partners first reported a position in Edwards Lifesciences in Q4 2022 and held it in 7 quarters.
  • FourThought Financial Partners's Edwards Lifesciences position peaked at $334K in Q2 2023.
  • 1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on FourThought Financial Partners's 13F filing for Q4 2025, filed 6 Feb 2026.